[HTML][HTML] Current status and future perspectives of lactate dehydrogenase detection and medical implications: a review

Y Zhou, M Qi, M Yang - Biosensors, 2022 - mdpi.com
The demand for glucose uptake and the accompanying enhanced glycolytic energy
metabolism is one of the most important features of cancer cells. Unlike the aerobic …

The emerging role of lactate in tumor microenvironment and its clinical relevance

S Chen, Y Xu, W Zhuo, L Zhang - Cancer Letters, 2024 - Elsevier
In recent years, the significant impact of lactate in the tumor microenvironment has been
greatly documented. Acting not only as an energy substance in tumor metabolism, lactate is …

[HTML][HTML] Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype

M Aprile, S Cataldi, C Perfetto, A Federico… - British Journal of …, 2023 - nature.com
Background B-raf inhibitors (BRAFi) are effective for BRAF-mutated papillary (PTC) and
anaplastic (ATC) thyroid carcinomas, although acquired resistance impairs tumour cells' …

[HTML][HTML] Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer

F Kitamura, T Semba, N Yasuda-Yoshihara… - JCI insight, 2023 - ncbi.nlm.nih.gov
Glycolysis is highly enhanced in pancreatic ductal adenocarcinoma (PDAC) cells; thus,
glucose restrictions are imposed on nontumor cells in the PDAC tumor microenvironment …

[HTML][HTML] Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma

F Li, W Si, L Xia, D Yin, T Wei, M Tao, X Cui, J Yang… - Molecular Cancer, 2024 - Springer
Background Metabolic reprogramming and epigenetic alterations contribute to the
aggressiveness of pancreatic ductal adenocarcinoma (PDAC). Lactate-dependent histone …

[HTML][HTML] Tumor biomarkers for diagnosis, prognosis and targeted therapy

Y Zhou, L Tao, J Qiu, J Xu, X Yang, Y Zhang… - … and Targeted Therapy, 2024 - nature.com
Tumor biomarkers, the substances which are produced by tumors or the body's responses to
tumors during tumorigenesis and progression, have been demonstrated to possess critical …

[HTML][HTML] Cancer bioenergetics and tumor microenvironments—Enhancing chemotherapeutics and targeting resistant niches through nanosystems

A Farhana, A Alsrhani, YS Khan, Z Rasheed - Cancers, 2023 - mdpi.com
Simple Summary Cancer remains a major killer of the human population. Current cancer
diagnostic and therapeutic methods are associated with shortcomings of limited targetability …

Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies

Z Wang, B Wu, G Nie, J Wei, Y Li - Cancer Letters, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal malignancy with insidious onset
and early distal metastasis. Metabolic reprogramming, the autonomous changes in cellular …

[HTML][HTML] Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?

F Borea, MA Franczak, M Garcia, M Perrino… - International journal of …, 2023 - mdpi.com
Malignant Pleural Mesothelioma (MPM) is a rare neoplasm that is typically diagnosed in a
locally advanced stage, making it not eligible for radical surgery and requiring systemic …

Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation

Y Zeng, H Jiang, X Zhang, J Xu, X Wu, Q Xu… - Free Radical Biology …, 2023 - Elsevier
Cisplatin (CPT) is one of the standard treatments for hepatocellular carcinoma (HCC).
However, its use is limits as a monotherapy due to drug resistance, and the underlying …